ARTICLE | Clinical News
PI-88: Completed Phase Ib trial enrollment
December 4, 2000 8:00 AM UTC
Progen Industries Ltd. (ASX:PGL; PGLAF), Brisbane, Australia Product: PI-88 Business: Cancer Therapeutic category: Angiogenesis Target: Blood vessels Description: Sulfated mannopentaose phosphate oli...